Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Editorial: HIV and cardiovascular disease: recognizing and reducing disparities

Editorial: HIV and cardiovascular disease: recognizing and reducing disparities EDITORIAL URRENT HIV and cardiovascular disease: recognizing and PINION reducing disparities a,b,c Virginia A. Triant INTRODUCTION determinants of health in relation to CVD risk in PWH is only beginning to be elucidated. Conse- Advances in antiretroviral therapy (ART) have quently, CVD in PWH is thought to be the result resulted in increased longevity for people with of a complex interplay of multiple factors and path- HIV (PWH). Yet, this aging HIV population is con- ways, with HIV itself and HIV-specific factors acting fronting a disproportionately increasing burden of as risk-enhancers [5]. Current strategies for risk- chronic noncommunicable diseases (NCDs) com- stratification, prevention, and management of pared with people without HIV [1]. Salient among CVD in PWH, however, are transported from the these chronic diseases that represent barriers to general population and do not reflect the unique healthy aging is cardiovascular disease (CVD) [2– factors – including sociodemographic and immu- 4]. Extensive research over the past decades indi- nologic – driving excess CVD risk in PWH [5,9,10]. cates that HIV-associated CVD is more prevalent, is Articles in this issue address current knowledge mechanistically distinct, and is undertreated com- and knowledge gaps across the spectrum of cardio- pared with CVD in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in HIV and AIDS Wolters Kluwer Health

Editorial: HIV and cardiovascular disease: recognizing and reducing disparities

Triant, Virginia A.
Current Opinion in HIV and AIDS , Volume 17 (5) – Sep 1, 2022
Download PDF
2 pages

Loading next page...
 
/lp/wolters-kluwer-health/editorial-hiv-and-cardiovascular-disease-recognizing-and-reducing-GaOJKUsZah

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1746-630X
eISSN
1746-6318
DOI
10.1097/coh.0000000000000757
Publisher site
See Article on Publisher Site

Abstract

EDITORIAL URRENT HIV and cardiovascular disease: recognizing and PINION reducing disparities a,b,c Virginia A. Triant INTRODUCTION determinants of health in relation to CVD risk in PWH is only beginning to be elucidated. Conse- Advances in antiretroviral therapy (ART) have quently, CVD in PWH is thought to be the result resulted in increased longevity for people with of a complex interplay of multiple factors and path- HIV (PWH). Yet, this aging HIV population is con- ways, with HIV itself and HIV-specific factors acting fronting a disproportionately increasing burden of as risk-enhancers [5]. Current strategies for risk- chronic noncommunicable diseases (NCDs) com- stratification, prevention, and management of pared with people without HIV [1]. Salient among CVD in PWH, however, are transported from the these chronic diseases that represent barriers to general population and do not reflect the unique healthy aging is cardiovascular disease (CVD) [2– factors – including sociodemographic and immu- 4]. Extensive research over the past decades indi- nologic – driving excess CVD risk in PWH [5,9,10]. cates that HIV-associated CVD is more prevalent, is Articles in this issue address current knowledge mechanistically distinct, and is undertreated com- and knowledge gaps across the spectrum of cardio- pared with CVD in

Journal

Current Opinion in HIV and AIDS – Wolters Kluwer Health

Published: Sep 1, 2022

References

  • Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies
  • Global burden of atherosclerotic cardiovascular disease in people living with HIV
  • Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease
  • HIV infection and the risk of acute myocardial infarction
  • Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association
  • CD4+ count-guided interruption of antiretroviral treatment
  • Immunologic basis of cardiovascular disease in HIV-infected adults
  • Inflammatory and coagulation biomarkers and mortality in patients with HIV infection
  • Cardiovascular risk prediction functions underestimate risk in HIV infection
  • Assessing and refining myocardial infarction risk estimation among patients with human immunodeficiency virus: a study by the Centers for AIDS Research Network of Integrated Clinical Systems